Import safety summit
This article was originally published in The Tan Sheet
FDA Commissioner Andrew von Eschenbach will moderate a discussion on the legal and regulatory safety and security requirements for the drug industry at the Import Safety Summit July 9 in Washington, the Consumer Healthcare Products Association announces. The summit, cosponsored by CHPA and other trade and advocacy groups, will include a keynote address by Health and Human Services Secretary Michael Leavitt and sessions on import safety challenges, standard-setting, auditing and certification efforts in an evolving global marketplace...
You may also be interested in...
At Repro-Med, James Beck has been replaced by Linda Tharby as CEO, and more.
Norway’s Pre Diagnostics uses the intracellular approach to neurodegenerative disease diagnosis. It believes its technology will open up a world of precision medicine for Alzheimer’s disease patients.
Coronavirus Notebook: New EMA Review To Contextualize Blood Clot Risk From AZ Jab, EU Gets Earlier Access To More Pfizer Vaccines
Denmark has stopped using the AstraZeneca vaccine completely, while the Canadian regulator is not recommending restrictions in any specific populations. Can a new EMA review provide better context to guide the vaccine’s use in different age groups and gender?